Syngenta Announces EXORT Technology Using Natural microRNAs to Boost Crop Yields

Syngenta has announced EXORT technology, a new agricultural biological platform the company states delivered consistent yield gains across major crops including rice, soybean, corn, cotton, vegetables and fruits in one of the largest biological field programmes of its kind, spanning multiple years and geographies. The first products based on the technology are planned for launch from 2027, with phased introduction planned across approximately 20 countries over subsequent years.

 

Why Applying Natural microRNAs Represents a Mechanistically Different Approach

 

The release describes EXORT technology as based on "natural microRNAs – tiny molecules found in plants that help regulate how biological instructions are used," which "act like signals that help orchestrate biological processes." Rather than introducing new genetic material into a plant, as genetic modification approaches do, or applying external synthetic chemical compounds, as conventional agrochemicals typically do, this technology instead applies "precisely selected naturally occurring microRNAs at field scale" to influence how a plant's existing biological processes already function.

That distinction matters mechanically because microRNAs function as regulatory signals within a plant's own existing genetic and biological machinery, rather than altering the plant's underlying genetic code or introducing an entirely external biochemical mechanism. Camilla Corsi, Syngenta's Head of Crop Protection Research & Development, specifically framed this as translating "a fundamental biological mechanism into a practical agricultural solution," positioning the approach as working with a plant's existing biological toolkit rather than adding new external genetic or chemical components to it.

 

Read more: CURA Raises $10 Million to Electrify Core Cement Production Process

 

Why the Nobel Prize Connection Provides Genuine Scientific Grounding

 

The release specifically notes this technology is "built on years of in-house research in the fast-growing scientific field of microRNAs – whose discovery transformed the field of biology and was recognized by the 2024 Nobel Prize in Physiology or Medicine." That reference isn't merely incidental scientific name-dropping; microRNA discovery and its biological significance represents a genuinely well-established and independently recognised area of biological science, distinct from an emerging or unproven scientific claim specific to this particular company's proprietary research alone.

That established scientific foundation matters for assessing the underlying credibility of applying microRNA-based approaches to agriculture specifically, since the fundamental biological mechanism, microRNAs functioning as regulatory signals within biological systems, has independent scientific validation extending well beyond Syngenta's own commercial research programme, even though the specific commercial application of precisely selected microRNAs to enhance crop yield performance represents Syngenta's own proprietary technological development building on that broader scientific foundation.

 

Explore OneStop ESG Marketplace: Biofertilizers

 

Why the Multi-Year Field Programme Scope Matters for Assessing the Yield Claims

 

The release describes this as "one of the largest biological field programs of its kind," with yield gains reported "across major crops... over multiple years and geographies," a scope that provides meaningfully more robust evidence than a single-season or single-location trial would offer. Testing across multiple growing seasons and diverse geographic locations helps account for the substantial year-to-year and location-to-location variability in agricultural performance driven by weather conditions, soil characteristics and regional growing practices, factors that could otherwise make a single favourable trial result difficult to distinguish from genuine, reproducible technology performance.

That said, the release doesn't specify the exact number of trial locations, years, or provide the underlying yield gain percentage figures themselves, nor does it reference independent third-party verification of these field programme results, meaning the specific magnitude and statistical robustness of the reported yield gains cannot be independently assessed from this release alone, a distinction worth maintaining until the company's underlying field trial data and methodology become more fully available, likely as the technology approaches its stated 2027 commercial launch.

 

Why the Low-Dose Foliar Application Method Matters for Adoption Practicality

 

The release specifically states products using EXORT technology are "applied at very small doses to the leaf" and work "without changing their normal field routine." That practical application detail matters for assessing how readily farmers might adopt this technology if it performs as described, since an agricultural input requiring farmers to substantially alter their existing equipment, timing or field operation procedures would face considerably greater adoption friction than one designed to integrate into farmers' already-established application routines and equipment, a consideration relevant to how quickly a genuinely effective new agricultural technology might achieve meaningful market penetration following its eventual commercial launch.

 

Source: Syngenta